Fibrosis: Clinical Trials

50 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 unknown. 50 Phase 1, 26 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 150Unknown 50
Phase 226Unknown 26

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 50 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds
DERMASEAL - Skin Graft Complications
Phase 1 / Phase 2UnknownHobart W. Harris122024-09-012024-06-11
Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.
Insulin group, Botulinum toxin group, Triamcinolone acetonide group - Keloid
Phase 1 / Phase 2UnknownAssiut University452024-05-012024-01-30
Ethosomal Gel Bearing Losartan 5% for Keloid Treatment
Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml - Keloid
Phase 1 / Phase 2UnknownYuni Eka Anggraini462024-03-302023-12-05
Subcutaneous Semaglutide in Systemic Scleroderma
Semaglutide Pen Injector - Scleroderma, Systemic, Fibrosis
Phase 1UnknownSecond Xiangya Hospital of Central South University102024-02-292024-03-05
To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis
Cell therapy - Cirrhosis, Liver
Phase 1UnknownAnhui Provincial Hospital92023-08-092024-03-06
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule
Ivaltinostat, Placebo - Hematologic Malignancy, Solid Tumor
Phase 1UnknownMachaon Biotherapeutics, Inc.322023-03-092023-10-23
Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells
Conventional therapy plus low dose UCMSCs treatment, Conventional therapy plus medium dose UCMSCs treatment, Conventional therapy plus high dose UCMSCs treatment - Alcoholic Cirrhosis
Phase 1UnknownYantai Yuhuangding Hospital362022-06-132023-03-28
A Single and Repeat Dose Trial in Participants With Hepatic Impairment
GB1211, Placebo - Hepatic Impairment
Phase 1 / Phase 2UnknownGalecto Biotech AB542021-09-092023-05-11
Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)
UC-MSCs, Saline solution - Cirrhosis Due to Hepatitis B
Phase 1 / Phase 2UnknownRenmin Hospital of Wuhan University202021-07-202022-08-19
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
Allogeneic Hepatocyte - Liver Cirrhosis
Phase 1UnknownRenJi Hospital202021-04-202021-03-19
The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19
MON002 - Pulmonary Fibrosis, Interstitial Lung Disease
Phase 1 / Phase 2UnknownGuy's and St Thomas' NHS Foundation Trust52021-03-082021-03-18
Effect of Imatinib in Advance Liver Fibrosis Patients
Imatinib 200mg, Placebo - Liver Fibrosis
Phase 1 / Phase 2UnknownResearch Institute for Gastroenterology and Liver Diseases (RIGLD)202021-02-202022-02-04
Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge
IN01 vaccine - Pulmonary Fibrosis, Covid19
Phase 1UnknownInstituto OncolĂłgico Dr Rosell402020-12-012020-09-24
Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid
Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium, Conditioned Medium, Triamcinolone Acetonide - Keloid
Phase 1 / Phase 2UnknownPT. Prodia Stem Cell Indonesia242020-09-012020-07-15
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
Collagen-Polyvinylpyrrolidone - Covid19, Cytokine Storm
Phase 1 / Phase 2UnknownJanette Furuzawa Carballeda902020-08-192021-02-17
Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease
MSC and Tregs - Liver Cirrhosis
Phase 1 / Phase 2UnknownNanjing Medical University302020-06-012020-03-04
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC
Cellgram™ (Bone marrow-derived MSCs) - Alcoholic Liver Cirrhosis
Phase 1UnknownPharmicell Co., Ltd.102019-06-202020-10-22
Mesenchymal Stem Cell Therapy for Liver Cirrhosis
Autologous BM MSC - Liver Cirrhosis
Phase 1 / Phase 2UnknownStem Med Pte. Ltd.202018-08-182021-03-17
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
Biopsy, Biospecimen Collection, Computed Tomography - Cirrhosis
Phase 1UnknownNational Cancer Institute (NCI)142018-08-092024-08-02
Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III
HF-LED-RL Phototherapy, Mock Therapy - Skin Diseases, Keloid
Phase 1UnknownVA Northern California Health Care System602018-01-312018-02-14

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (23)  ·  Cicatrix (8)  ·  Keloid (4)  ·  Pulmonary Fibrosis (4)  ·  COVID-19 (3)  ·  End Stage Liver Disease (3)  ·  Liver Cirrhosis, Biliary (3)  ·  Liver Diseases (3)  ·  Hepatitis C (2)  ·  Liver Cirrhosis, Alcoholic (2)  ·  Bronchiectasis (1)  ·  Cystic Fibrosis (1)  ·  Cytokine Release Syndrome (1)  ·  Digestive System Diseases (1)

Broader conditions

Pathologic Processes (50)  ·  Pathological Conditions, Signs and Symptoms (50)  ·  Digestive System Diseases (29)  ·  Liver Diseases (26)  ·  Connective Tissue Diseases (5)  ·  Infections (5)  ·  Liver Cirrhosis (5)  ·  RNA Virus Infections (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Virus Diseases (5)  ·  Collagen Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)

Interventions

Triamcinolone Acetonide (2)  ·  Ursodeoxycholic Acid (2)  ·  Biopsy (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Colchicine (1)  ·  Congresses as Topic (1)  ·  Control Groups (1)  ·  Culture Media, Conditioned (1)  ·  Drug Therapy (1)  ·  Fecal Microbiota Transplantation (1)  ·  High-Energy Shock Waves (1)  ·  Imatinib Mesylate (1)  ·  Interferons (1)  ·  Lamivudine (1)  ·  MON002 (1)

Sponsors

Air Force Military Medical University, China (3)  ·  Assiut University (2)  ·  Baermed (2)  ·  National Center for Research Resources (NCRR) (2)  ·  AdiSave Inc. (1)  ·  Aegeria Soft Tissue LLC (1)  ·  Alliancells Bioscience Corporation Limited (1)  ·  Anhui Provincial Hospital (1)  ·  Beijing 302 Hospital (1)  ·  Chaitanya Hospital, Pune (1)  ·  Clinica las Condes, Chile (1)  ·  Fast Forward Pharmaceuticals (1)  ·  First Affiliated Hospital of Chengdu Medical College (1)  ·  Galecto Biotech AB (1)  ·  General Hospital of Chinese Armed Police Forces (1)

Countries

China (19)  ·  United States (6)  ·  United Kingdom (4)  ·  Indonesia (2)  ·  Netherlands (2)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Egypt (1)  ·  India (1)  ·  Iran (1)  ·  Italy (1)  ·  Mexico (1)  ·  Puerto Rico (1)

Top investigators

Daiming Fan (3)  ·  Aiwu R He (1)  ·  Amit Patel, MD (1)  ·  Ashish Patel, PhD FRCS (1)  ·  Baoyong Yan, doctor (1)  ·  Bijan Modarai, PhD FRCS (1)  ·  Charlie Xiang, Professor (1)  ·  Daniel Azamar-Llamas, MD (1)  ·  David M Young, MD (1)  ·  Eric Ochoa-Hein, MD (1)  ·  Fengchun Zhang, MD (1)  ·  Fu-Sheng Wang, professor (1)

Results publications

PMID 10415784, PMID 12563677, PMID 14719037, PMID 15663512, PMID 17181919, PMID 18097874, PMID 19397687, PMID 19453649, PMID 19998041, PMID 21131395, PMID 22028728, PMID 22545014, PMID 22731679, PMID 24876849, PMID 26006200, PMID 26867177, PMID 28584818, PMID 30473697, PMID 30894210, PMID 31986264, PMID 32035018, PMID 32089354, PMID 32113509, PMID 32125455, PMID 32159775, PMID 32192578, PMID 32203186, PMID 32234467, PMID 32257537, PMID 32278362, PMID 32283152, PMID 32360286, PMID 32396163, PMID 33123384, PMID 34282853, PMID 38167064, PMID 39358661, PMID 9804346

NIH funding

2009 (1), 2014 (1), M01RR000051 (1), N01CN00035 (1), P30CA060553 (1)